IL-17A-BINDENDE PROTEINE
European patent · EP3247724 · Deleted
Register entry
- Publication number
- EP3247724
- Application number
- EP16700518
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Jan 12, 2016
- Published
- Nov 29, 2017
- Granted
- Mar 12, 2025
- Deleted
- Aug 25, 2026
- Reason
- Annual fee unpaid
- IPC classes
- C07K 16/24 (2006.01)
- Priority
- GB 201500463 12.01.2015
- PCT application
- PCT/GB2016/050070 12.01.2016
- PCT publication
- WO2016/113557 21.07.2016
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 25, 2026
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 25.08.2026
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 25.08.2026
- Jan 21, 2026
Change
Published in Swissreg on 21.01.2026
- Mar 19, 2025
Change
Published in Swissreg on 19.03.2025
- Mar 12, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 12.03.2025
- Mar 12, 2025
Owner
- Owner
- Crescendo Biologics Limited, Meditrina Building, Babraham Research Campus, Babraham, Cambridge, CB22 3AT, United Kingdom → Crescendo Biologics Limited, 50/60 Station Road, c/o We Work, Cambridge CB1 2JH, United Kingdom
Published in Swissreg on 12.03.2025
Parties
Inventor
Cambridge Cambridgeshire CB22 3AT, GB
Cambridge Cambridgeshire CB22 3AT, GB
Cambridge Cambridgeshire CB22 3AT, GB
Cambridge Cambridgeshire CB22 3AT, GB
Cambridge Cambridgeshire CB22 3AT, GB
Cambridge Cambridgeshire CB22 3AT, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.